Evidence map›Paper›PMID 35033972›Full record

ReviewDevelopmental cognitive neuroscience2022

Remote and at-home data collection: Considerations for the NIH HEALthy Brain and Cognitive Development (HBCD) study.

Sean C L Deoni, Viren D'Sa, Alexandra Volpe, Jennifer Beauchemin, Julie M Croff, Amy J Elliott, Nicolò Pini, Maristella Lucchini, William P Fifer

Open access · goldAbstract readReview
In one paragraph

Review in Developmental cognitive neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Low-field MRI: Clinical promise and challenges.Journal of magnetic resonance imaging : JMRI · 2023
    Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Sean C L DeoniMaternal, Newborn, and Child Health Discovery & Tools, Bill & Melinda Gates Foundation, Seattle, WA, USA; Advanced Baby Imaging Lab, Rhode Island Hospital, Providence, RI, USA; Department of Pediatrics, Warren Alpert Medical School at Brown University, Providence, RI, USA. Electronic address: sean.deoni@gatesfoundation.org.
Viren D'SaAdvanced Baby Imaging Lab, Rhode Island Hospital, Providence, RI, USA; Department of Pediatrics, Warren Alpert Medical School at Brown University, Providence, RI, USA.
Alexandra VolpeAdvanced Baby Imaging Lab, Rhode Island Hospital, Providence, RI, USA; Department of Pediatrics, Warren Alpert Medical School at Brown University, Providence, RI, USA.
Jennifer BeaucheminAdvanced Baby Imaging Lab, Rhode Island Hospital, Providence, RI, USA; Department of Pediatrics, Warren Alpert Medical School at Brown University, Providence, RI, USA.
Julie M CroffCenter for Health Sciences, National Center for Wellness and Recovery, Oklahoma State University, Tulsa, USA.
Amy J ElliottAvera Research Institute, Sioux Falls, SD, USA.
Nicolò PiniDepartment of Psychiatry and Pediatrics, Columbia University Medical Center, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA.
Maristella LucchiniDepartment of Psychiatry and Pediatrics, Columbia University Medical Center, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA.
William P FiferDepartment of Psychiatry and Pediatrics, Columbia University Medical Center, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA.
Brown University · USColumbia University Irving Medical Center · USAvera Health · USNew York State Psychiatric InstituteOklahoma State University Center for Health Sciences · USRhode Island Hospital · US

Funding

The Healthy Brain and Child Development National Consortium Administrative CoreU24DA055325 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHRISTINA CHAMBERS, CHARLES Alexander NELSON · 2021 to 2026
$40.8M
The Developing Brain: Influences and OutcomesUG3OD023313 · OD · UNIVERSITY OF COLORADO DENVER · PI D'SA, VIREN ANDREW, KOINIS MITCHELL, DAPHNE · 2016 to 2024
$11.6M
2/5 The Cumulative Risk of Substance Exposure and Early Life Adversity on Child Health Development and OutcomesR34DA050288 · NIDA · AVERA MCKENNAN · PI ELLIOTT, AMY J · 2019 to 2020
$697k
1/5 The Cumulative Risk of Substance Exposure and Early Life Adversity on Child Health Development and OutcomesR34DA050284 · NIDA · RHODE ISLAND HOSPITAL · PI AMSO, DIMA, D'SA, VIREN ANDREW · 2019 to 2020
$640k
Understanding the effects of COVID-19 on maternal substance useR34DA050343 · NIDA · OSU CENTER FOR HEALTH SCIENCES · PI CROFF, JULIE MAY, MORRIS, AMANDA S · 2019 to 2020
$598k
Gates Foundation INV-005774NIDA NIH HHS R34 DA050284NIDA NIH HHS R34 DA050288NIDA NIH HHS R34 DA050343NIDA NIH HHS U24 DA055325NIH HHS UG3 OD023313
6 · The paper itself

Abstract

The NIH HEALthy Brain and Cognitive Development (HBCD) study aims to characterize the impact of in utero exposure to substances, and related environmental exposures on child neurodevelopment and health outcomes. A key focus of HBCD is opioid exposure, which has disproportionately affected rural areas. While most opioid use and neonatal abstinence syndrome has been reported outside of large cities, rural communities are often under-represented in large-scale clinical research studies that involve neuroimaging, in-person assessments, or bio-specimen collections. Thus, there exists a likely mismatch between the communities that are the focus of HBCD and those that can participate. Even geographically proximal participants, however, are likely to bias towards higher socioeconomic status given the anticipated study burden and visit frequency. Wearables, 'nearables', and other consumer biosensors, however, are increasingly capable of collecting continuous physiologic and environmental exposure data, facilitating remote assessment. We review the potential of these technologies for remote in situ data collection, and the ability to engage rural, affected communities. While not necessarily a replacement, these technologies offer a compelling complement to traditional 'gold standard' lab-based methods, with significant potential to expand the study's reach and importance.

Indexed as

Analgesics, OpioidBrainChildCognitionHumansInfant, NewbornNeuroimagingAnalgesics, OpioidChild developmentEnvironmental exposureMobile MRINeurodevelopmentPersonal technologyRemote data collection

Identifiers

PMID35033972
PMCPMC8762360
OpenAlexW4205459720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.